DigiNepal

Chinese drug Loberamisal extends stroke treatment window from 6 hours to 2 days

Chinese drug Loberamisal extends stroke treatment window from 6 hours to 2 days

Chinese drug Loberamisal extends stroke treatment window from 6 hours to 2 days

Chinese medical scientists have shattered the brief window of time available to limit stroke damage, effectively shielding injured brain cells and dramatically improving the odds of a full recovery. Brain cells start dying within minutes of a clot blocking an artery, leading to facial droop, affected speech and in severe cases, paralysis or death. Emergency treatments, such as clot-busting drugs…

www.scmp.com/news/china/science/article/3368614/chinese-drug-loberamisal-extends-stroke-treatment-window-6-hours-2-days?utm_source=rss_feed

Open in DigiNepal →